|
1.
|
Carden DL and Granger DN: Pathophysiology
of ischaemia-reperfusion injury. J Pathol. 190:255–266. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Chatterjee PK: Novel pharmacological
approaches to the treatment of renal ischemia-reperfusion injury: a
comprehensive review. Naunyn Schmiedebergs Arch Pharmacol.
376:1–43. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Li MD: Leptin and beyond: an odyssey to
the central control of body weight. Yale J Biol Med. 84:1–7.
2011.PubMed/NCBI
|
|
4.
|
Cao R, Brakenhielm E, Wahlestedt C, et al:
Leptin induces vascular permeability and synergistically stimulates
angiogenesis with FGF-2 and VEGF. Proc Natl Acad Sci USA.
98:6390–6395. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Wolf G, Hamann A, Han DC, et al: Leptin
stimulates proliferation and TGF-beta expression in renal
glomerular endothelial cells: potential role in glomerulosclerosis.
Kidney Int. 56:860–872. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Mastronardi CA, Yu WH and McCann SM:
Resting and circadian release of nitric oxide is controlled by
leptin in male rats. Proc Natl Acad Sci USA. 99:5721–5726. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Lin J, Yan GT, Wang LH, et al: Leptin
fluctuates in intestinal ischemia-reperfusion injury as
inflammatory cytokine. Peptides. 25:2187–2193. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Shi Y, Yan GT, Lin J, et al: Intestinal
ischemia-reperfusion injury made leptin decreased. Regul Pept.
133:27–31. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Kleinz MJ and Davenport AP: Emerging roles
of apelin in biology and medicine. Pharmacol Ther. 107:198–211.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Hacioglu A, Algin C, Pasaoglu O, et al:
Protective effect of leptin against ischemia-reperfusion injury in
the rat small intestine. BMC Gastroenterol. 5:372005. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Pan CS, Teng X, Zhang J, et al: Apelin
antagonizes myocardial impairment in sepsis. J Card Fail.
16:609–617. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Kaya H, Balcı TA, Cobaner A, et al:
Evaluation on the renal tubular damage in rats with acute
haemorrhagic hypovolemic shock using Tc-99m DMSA uptake
scintigraphy. Turk J Nucl Med. 12:85–89. 2003.
|
|
13.
|
Parra C, Salas P and Dominguez J: Effects
of immunosuppressive drugs on rat renal ischemia reperfusion
injury. Transplant Proc. 42:245–247. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Yamamoto S, Hagiwara S, Hidaka S, et al:
The antioxidant EPC-K1 attenuates renal ischemia-reperfusion injury
in a rat model. Am J Nephrol. 33:485–490. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Koga H, Hagiwara S, Kusaka J, et al: Human
atrial natriuretic peptide attenuates renal ischemia-reperfusion
injury. J Surg Res. Nov 4–2010.(Epub ahead of print).
|
|
16.
|
Medeiros PJ, Villarim Neto A, Lima FP, et
al: Effect of sildenafil in renal ischemia/reperfusion injury in
rats. Acta Cir Bras. 25:490–495. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Prókai A, Fekete A, Bánki NF, et al:
Renoprotective effect of erythropoietin in rats subjected to
ischemia/reperfusion injury: gender differences. Surgery.
150:39–47. 2011.PubMed/NCBI
|
|
18.
|
Regner KR, Nilakantan V, Ryan RP, et al:
Protective effect of Lifor solution in experimental renal
ischemia-reperfusion injury. J Surg Res. 164:291–297. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Zhang L, Huang H, Cheng J, et al:
Pre-treatment with isoflurane ameliorates renal
ischemic-reperfusion injury in mice. Life Sci. 88:1102–1107. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Vianna PT, Castiglia YM, Braz JR, et al:
Remifentanil, isoflurane, and preconditioning attenuate renal
ischemia/reperfusion injury in rats. Transplant Proc. 41:4080–4082.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Simpkin JC, Yellon DM, Davidson SM, et al:
Apelin-13 and apelin-36 exhibit direct cardioprotective activity
against ischemia-reperfusion injury. Basic Res Cardiol.
102:518–528. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Zeng XJ, Zhang LK, Wang HX, et al: Apelin
protects heart against ischemia/reperfusion injury in rat.
Peptides. 30:1144–1152. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Malyszko J, Malyszko JS, Pawlak K, et al:
Apelin, a novel adipocytokine, in relation to endothelial function
and inflammation in kidney allograft recipients. Transplant Proc.
40:3466–3469. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Kunduzova O, Alet N, Delesque-Touchard N,
et al: Apelin/APJ signaling system: a potential link between
adipose tissue and endothelial angiogenic processes. FASEB J.
22:4146–4153. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Malyszko J, Malyszko JS, Pawlak K, et al:
Visfatin and apelin, new adipocytokines, and their relation to
endothelial function in patients with chronic renal failure. Adv
Med Sci. 53:32–36. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Principe A, Melgar-Lesmes P,
Fernández-Varo G, et al: The hepatic apelin system: a new
therapeutic target for liver disease. Hepatology. 48:1193–1201.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Sukhotnik I, Helou H, Lurie M, et al: The
effect of leptin on intestinal recovery following
ischemia-reperfusion injury in a rat. Pediatr Surg Int. 23:473–478.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Hus-Citharel A, Bouby N, Frugière A, et
al: Effect of apelin on glomerular hemodynamic function in the rat
kidney. Kidney Int. 74:486–494. 2008. View Article : Google Scholar : PubMed/NCBI
|
